Evolution of the Average Target: The Allstate Corporation

Evolution of the Average Target - The Allstate Corporation

Evolution of the Target Price: The Allstate Corporation

Evolution of the Target Price - The Allstate Corporation

Changes in Analyst Recommendations: The Allstate Corporation

ae18a3d1e4f81dc.Lpd3rAiN4tTc9g4E-51geRf8USnlWb3TWeLt8pxl29s.H84Gx2njjqGdgD5St94zFCeSC2TXFtmlIbS8lO4tmYli-CfkQu-Jpa-vQw~ac832842f42d69c8b068ad6ddff33d2a
10-12 Allstate Shares Rise After Wells Fargo Upgrade MT
10-12 BofA Adjusts Price Target on Allstate to $340 From $336, Keeps Buy Rating MT
10-12 Wells Fargo Upgrades Allstate to Equalweight From Underweight, Price Target is $236 MT
10-08 Evercore ISI Adjusts Allstate Price Target to $262 From $240 MT
10-07 Mizuho Adjusts Price Target on Allstate to $295 From $300 MT
10-07 HSBC Upgrades Allstate to Buy, $266 Price Target MT
10-07 Analyst recommendations: Lululemon, Marvell, Coinbase, Microsoft, Robinhood… Zonebourse
10-06 Barclays Adjusts Allstate Price Target to $221 From $226, Maintains Underweight Rating MT
10-06 Jefferies & Co Adjusts Allstate Price Target to $292 From $310, Maintains Buy Rating MT
10-05 Morgan Stanley Cuts Price Target on Allstate to $240 From $265 MT
10-05 Morgan Stanley Cuts Price Target on Allstate to $240 From $265, Keeps Equalweight Rating MT
10-01 BofA Securities Adjusts Price Target on Allstate to $336 From $334 MT
10-01 Goldman Sachs Adjusts Price Target on Allstate to $250 From $280, Maintains Neutral Rating MT
09-23 TD Cowen Adjusts Allstate Price Target to $260 From $231, Maintains Hold Rating MT
09-18 Mizuho Securities Adjusts Allstate Price Target to $297 From $300, Maintains Outperform Rating MT
09-16 Mizuho Securities Adjusts Allstate Price Target to $297 From $300, Maintains Outperform Rating MT
08-28 Argus Research Downgrades Allstate to Hold From Buy MT
08-26 Autonomous Research Adjusts Price Target on Allstate to $224 From $211 MT
08-20 Keefe Bruyette & Woods Downgrades Allstate to Underperform From Market Perform, Adjusts PT to $250 From $255 MT
08-20 Analyst recommendations: Datadog, Merck, Estee Lauder, Moderna, Target… Zonebourse
08-13 BMO Capital Adjusts Price Target on Allstate to $284 From $250, Keeps Outperform Rating MT
08-11 Morgan Stanley Adjusts Price Target on Allstate to $265 From $240, Maintains Equalweight Rating MT
08-11 Raymond James Adjusts Price Target on Allstate to $315 From $300, Keeps Strong Buy Rating MT
08-11 JPMorgan Adjusts Price Target on Allstate to $292 From $282, Keeps Overweight Rating MT
08-11 Citigroup Downgrades Allstate to Sell From Neutral, Adjusts Price Target to $240 From $226 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.62%
-0.39%
+2.16%
-4.97%
+2.33%
+42.93%
+19.32%
+7.08%
+6.97%
+2.37%
Average +8.14%
Weighted average by Cap. +5.60%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
259.87USD
Average target price
269.27USD
Spread / Average Target
+3.62%
High Price Target
340.00USD
Spread / Highest target
+30.83%
Low Price Target
191.00USD
Spread / Lowest Target
-26.50%

Analyst Consensus Detail

Analyst consensus - The Allstate Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - The Allstate Corporation
Trader
Investor
-
Global
-
Quality
ESG MSCI
AA
MarketScreener Ratings - The Allstate Corporation
  1. Stock Market
  2. Stocks
  3. ALL Stock
  4. Consensus The Allstate Corporation